Cargando…
Combined antitumoral effects of pretubulysin and methotrexate
Pretubulysin (PT), a potent tubulin‐binding antitumoral drug, and the well‐established antimetabolite methotrexate (MTX) were tested separately or in combination (PT+MTX) for antitumoral activity in L1210 leukemia cells or KB cervix carcinoma cells in vitro and in vivo in NMRI‐nu/nu tumor mouse mode...
Autores principales: | Kern, Sarah, Truebenbach, Ines, Höhn, Miriam, Gorges, Jan, Kazmaier, Uli, Zahler, Stefan, Vollmar, Angelika M., Wagner, Ernst |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343018/ https://www.ncbi.nlm.nih.gov/pubmed/30693087 http://dx.doi.org/10.1002/prp2.460 |
Ejemplares similares
-
Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy
por: Herrmann, Jennifer, et al.
Publicado: (2012) -
Pretubulysin: a new option for the treatment of metastatic cancer
por: Braig, S, et al.
Publicado: (2014) -
The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cells
por: Schwenk, Rebecca, et al.
Publicado: (2017) -
The Microtubule-Targeting Agent Pretubulysin Impairs the Inflammatory Response in Endothelial Cells by a JNK-Dependent Deregulation of the Histone Acetyltransferase Brd4
por: Primke, Tobias F., et al.
Publicado: (2023) -
Turning the Actin Nucleating Compound Miuraenamide
into Nucleation Inhibitors
por: Wang, Shuaijun, et al.
Publicado: (2021)